Ahmed Hashim1, Margaret O'Sullivan2, Hugh Williams3, Sumita Verma1. 1. 1Department of Medicine,Brighton and Sussex Medical School,Brighton,UK. 2. 2Department of Gastroenterology and Hepatology,Brighton and Sussex University Hospital,Brighton,UK. 3. 3Pavilions Drug & Alcohol Services,Richmond House,Brighton,UK.
Abstract
Background and aims Majority of the individuals with hepatitis C virus (HCV) infection in England are people who inject drugs, a vulnerable and disenfranchised cohort with poor engagement with secondary care. Our aim is to describe our experiences in setting up a successful nurse led HCV service at a substance misuse service (SMS). METHODS: We justify the need for a community HCV service and review the different community based models. Our experiences in engaging with stakeholders, obtaining funding, service set up, challenges faced and key recommendations are discussed. Finally, a summary of interim clinical outcomes is presented. RESULTS: A successful community based "one-stop" nurse led HCV service was set up in Dec 2013 at a large SMS. It provides all aspects of care (blood borne virus screening, non-invasive assessment of hepatic fibrosis, Hepatology input, HCV treatment, peer mentor, social and psychiatrist support, and opiod substitution) at one site. Interim clinical data indicate high service uptake with HCV treatment outcomes comparable to secondary care. CONCLUSIONS: The advent of direct acting antivirals provides a unique opportunity for HCV elimination in England by 2030. Our "one-stop" integrated and multidisciplinary community HCV model suggests that HCV care can be successfully delivered outside of a hospital setting and warrants national adoption.
Background and aims Majority of the individuals with hepatitis C virus (HCV) infection in England are people who inject drugs, a vulnerable and disenfranchised cohort with poor engagement with secondary care. Our aim is to describe our experiences in setting up a successful nurse led HCV service at a substance misuse service (SMS). METHODS: We justify the need for a community HCV service and review the different community based models. Our experiences in engaging with stakeholders, obtaining funding, service set up, challenges faced and key recommendations are discussed. Finally, a summary of interim clinical outcomes is presented. RESULTS: A successful community based "one-stop" nurse led HCV service was set up in Dec 2013 at a large SMS. It provides all aspects of care (blood borne virus screening, non-invasive assessment of hepatic fibrosis, Hepatology input, HCV treatment, peer mentor, social and psychiatrist support, and opiod substitution) at one site. Interim clinical data indicate high service uptake with HCV treatment outcomes comparable to secondary care. CONCLUSIONS: The advent of direct acting antivirals provides a unique opportunity for HCV elimination in England by 2030. Our "one-stop" integrated and multidisciplinary community HCV model suggests that HCV care can be successfully delivered outside of a hospital setting and warrants national adoption.
Entities:
Keywords:
CLD; HCV; PWID; community model; hepatitis C
Authors: I M Gralnek; R D Hays; A Kilbourne; H R Rosen; E B Keeffe; L Artinian; S Kim; D Lazarovici; D M Jensen; R W Busuttil; P Martin Journal: Am J Gastroenterol Date: 2000-12 Impact factor: 10.864
Authors: W L Irving; S Smith; R Cater; S Pugh; K R Neal; C A C Coupland; S D Ryder; B J Thomson; M Pringle; M Bicknell; J Hippisley-Cox Journal: J Viral Hepat Date: 2006-04 Impact factor: 3.728
Authors: F Kanwal; B M R Spiegel; R D Hays; F Durazo; S B Han; S Saab; R Bolus; S J Kim; I M Gralnek Journal: Aliment Pharmacol Ther Date: 2008-07-30 Impact factor: 8.171
Authors: Shruti H Mehta; Becky L Genberg; Jacquie Astemborski; Ravi Kavasery; Gregory D Kirk; David Vlahov; Steffanie A Strathdee; David L Thomas Journal: J Community Health Date: 2008-06
Authors: Herbert L Bonkovsky; Alan D Tice; Rockford G Yapp; Henry C Bodenheimer; Alexander Monto; Stephen J Rossi; Mark S Sulkowski Journal: Am J Gastroenterol Date: 2008-08-05 Impact factor: 10.864
Authors: Jayant A Talwalkar; David M Kurtz; Scott J Schoenleber; Colin P West; Victor M Montori Journal: Clin Gastroenterol Hepatol Date: 2007-10 Impact factor: 11.382
Authors: M Wilkinson; V Crawford; A Tippet; F Jolly; J Turton; E Sims; M Hekker; J Dalton; R Marley; G R Foster Journal: Aliment Pharmacol Ther Date: 2008-08-26 Impact factor: 8.171
Authors: Carlos Roncero; Pablo Ryan; Richard Littlewood; Juan Macías; Juan Ruiz; Pedro Seijo; Raúl Felipe Palma-Álvarez; Pablo Vega Journal: Hepat Med Date: 2018-12-24